Portola Pharmaceuticals Inc (PTLA)

54.14
1.40 2.60
NASDAQ : Health Care
Prev Close 52.78
Open 52.80
Day Low/High 52.57 / 54.34
52 Wk Low/High 18.20 / 57.95
Volume 563.64K
Avg Volume 1.07M
Exchange NASDAQ
Shares Outstanding 57.82M
Market Cap 3.05B
EPS -4.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Portola Pharmaceuticals, Inc. Investors (PTLA)

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Portola Pharmaceuticals, Inc. Investors (PTLA)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Portola Pharmaceuticals, Inc.

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Jim Cramer is bullish on Norwegian Cruise Line, iRobot, Bank of America, Portola Pharmaceuticals and more.

What's Getting In This Rally's Way: Cramer's 'Mad Money' Recap (Thurs 8/24/17)

What's Getting In This Rally's Way: Cramer's 'Mad Money' Recap (Thurs 8/24/17)

Why is this market so lacking in follow-through? Jim Cramer says the guy in the White House is only part of the problem.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Cramer: Don't Risk It All on a Small Biotech Unless You're Willing to Lose It All

Cramer: Don't Risk It All on a Small Biotech Unless You're Willing to Lose It All

Without at least one approved drug, I am tempted to say you should just take a pass.

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'

Short Interest In Portola Pharmaceuticals Drops 26.2%

Short Interest In Portola Pharmaceuticals Drops 26.2%

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,410,701 share decrease in total short interest for Portola Pharmaceuticals, Inc. , to 3,978,700, a decrease of 26.18% since 06/15/2017.

NovoCure, NextEra, O'Reilly: 'Mad Money' Lightning Round (7/7/17)

NovoCure, NextEra, O'Reilly: 'Mad Money' Lightning Round (7/7/17)

A look at Jim Cramer's thoughts on stocks of interest to "Mad Money" viewers.

What to Watch During the Week: Cramer's 'Mad Money' Recap (Friday 7/7/17)

What to Watch During the Week: Cramer's 'Mad Money' Recap (Friday 7/7/17)

Earnings and Fed speakers are on tap in the next few days.

These 3 Small Biotechs Have a Healthy Shot

These 3 Small Biotechs Have a Healthy Shot

Several firms hiked price targets on Portola into the $70s this week.

Give These 3 Small Biotechs a Shot

Give These 3 Small Biotechs a Shot

Several firms hiked price targets on Portola into the $70s this week.

Biotech Stocks Showing Signs Of Resurgence

MarketNewsUpdates.com News Commentary

Here Comes a Big Breakout For Alibaba

Here Comes a Big Breakout For Alibaba

What the charts say.

TheStreet Quant Rating: D (Sell)